Press Releases April 28, 2026 06:00 PM

HII’s Ingalls Shipbuilding is Awarded Frigate Lead Yard Support Contract

HII’s Ingalls Shipbuilding awarded $283 million contract for lead yard support activities on U.S. Navy's new FF(X) frigate program

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
HII

HII's Ingalls Shipbuilding division has been awarded a $283 million contract by the U.S. Navy to perform lead yard support activities for the new FF(X) class frigate. This contract initiates procurement of long-lead materials, design work, and pre-construction efforts for the first frigate, leveraging the proven Legend-class national security cutter design. Ingalls has invested over $1 billion in facility modernization to support steady delivery of next-generation naval platforms, reinforcing HII's position as a key player in U.S. defense shipbuilding.

HII’s Ingalls Shipbuilding is Awarded Frigate Lead Yard Support Contract
HII
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • HII's Ingalls Shipbuilding secured a $283 million contract for the FF(X) frigate lead yard support from the U.S. Navy.
  • The contract enables early material procurement and pre-construction, accelerating frigate production based on a proven ship design.
  • Ingalls operates alongside production lines for various U.S. Navy warships and has invested over $1 billion in modernizing facilities to meet Navy demand.

PASCAGOULA, Miss., April 28, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that the U.S. Navy awarded its Ingalls Shipbuilding division a $283 million contract to perform FF(X) class frigate lead yard support activities for the new frigate class. The contract allows Ingalls Shipbuilding to procure long lead time material, execute design work and begin pre-construction activities for the first ship.

“We are proud of our past performance in engineering, design and production of warships that meet U.S. military standards, a performance that gave the Navy confidence to select the national security cutter as the basis for the next small surface combatant and to choose Ingalls as the program’s lead yard,” said Brian Blanchette, Ingalls Shipbuilding president. “We are excited to partner with the Navy to bring these preproduction steps under contract to accelerate delivery of the frigates that our warfighters need.”

Under this contract, Ingalls Shipbuilding will begin cutting and shaping raw material to support future phases of work on the main structure foundation and the overall construction sequencing plan of the first frigate. This new approach will enable a smooth transition from design to production at Ingalls Shipbuilding and eventually across the industrial base.


A photo accompanying this release is available at: http://hii.com/news/hiis-ingalls-shipbuilding-is-awarded-frigate-lead-yard-support-contract/.

In December 2025, the U.S. Navy selected Ingalls Shipbuilding to design and build the future FF(X), leveraging the stable and proven design of the Legend-class national security cutter (NSC). Ingalls previously delivered 10 NSCs to the U.S. Coast Guard and will use the same proven build sequence for the FF(X) program. The new frigates will be constructed alongside production lines that currently support DDG 51 Flight III destroyers, LHA assault ships, LPD Flight II amphibious transport docks, and modernization activities for the Zumwalt-class guided missile destroyers.

To meet urgent Navy demand and support construction of next-generation platforms, Ingalls Shipbuilding has invested more than $1 billion in modernizing its infrastructure, facilities, and toolsets. HII as a whole is actively working to expand U.S. shipbuilding capacity by, among other things, increasing the number of distributed shipbuilding partners, collaborating with international manufacturers, and evaluating the addition of another U.S. shipyard.

The Navy’s new class of smaller combatant ships, the FF(X), is a critical component of the Navy’s fleet of the future. The FF(X) will be a smaller, more agile surface combatant designed to complement the fleet’s larger, multi-mission warships and enhance operational flexibility around the globe.

About HII

HII is America’s largest shipbuilder, delivering the world’s most powerful ships and all-domain mission technologies, including unmanned systems, to U.S. and allied defense customers. HII is the largest producer of unmanned underwater vehicles for the U.S. Navy and the world.

With a more than 140-year history of advancing U.S. national security, HII builds and integrates defense capabilities extending from the core fleet to C6ISR, AI/ML, EW and synthetic training. Headquartered in Virginia, HII’s workforce is 44,000 strong. For more information, visit:

  • HII on the web: https://www.HII.com/
  • HII on Facebook: https://www.facebook.com/TeamHII
  • HII on X: https://www.twitter.com/WeAreHII
  • HII on Instagram: https://www.instagram.com/WeAreHII
  • HII on LinkedIn: https://www.linkedin.com/company/wearehii

Contact:

Kimberly Aguillard
[email protected]
(228) 355-5663

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/afda0ff0-5e5b-4592-a011-95c3b76c2e49


Risks

  • The success of FF(X) program depends on smooth transition from design to production, which may face technical or logistical challenges.
  • Budgetary fluctuations or changes in U.S. defense spending priorities could impact contract funding and timelines.
  • Competition and industrial base capacity constraints could affect delivery schedules and cost efficiency.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026